These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. [Compliance to therapy in daily practice--rheumatologic diseases]. Gerster JC Schweiz Rundsch Med Prax; 1993 Nov; 82(48):1381-3. PubMed ID: 8296118 [TBL] [Abstract][Full Text] [Related]
45. The use of "celestone chronodose" in the local treatment of musculo-skeletal disorders. Corrigan AB Med J Aust; 1966 Jun; 1(25):1063-4. PubMed ID: 5329351 [No Abstract] [Full Text] [Related]
46. [Results of the use of a new synthetic corticoid: betamethasone phosphate]. Gaubert ; Couture ; Jeanneton ; Demichel J Med Bord; 1965 Jun; 142(6):1108-14. PubMed ID: 5839538 [No Abstract] [Full Text] [Related]
47. [In which rheumatologic diseases is the immunologic etiology of importance?]. Lenoch F Z Gesamte Inn Med; 1969 May; 24(9):136-9. PubMed ID: 5306827 [No Abstract] [Full Text] [Related]
48. [Compliance with anti-inflammatory therapy in rheumatologic pathology among outpatients. Value of single daily dose]. Delcambre B Sem Hop; 1980 Oct 18-25; 56(39-40):1563-5. PubMed ID: 6255568 [No Abstract] [Full Text] [Related]
49. [Experimentation with Bufexamac in the rheumatologic clinic]. Dumoulin J; Clauses I Rhumatologie; 1970 Nov; 22(9):351-5. PubMed ID: 5313703 [No Abstract] [Full Text] [Related]